EDITORIAL SECTION

Articles

Partnership & Collaboration: The Strategic Force Shaping the Future of Pharmaceutical Growth

The pharmaceutical industry is being reshaped by a simple but powerful reality no company however large or capable can build every capability alone The sector is operating in an environment defined

Blockchain in Pharma: Strengthening Drug Traceability, Compliance, and Supply Chain Security

For most of the last decade the European pharmaceutical industry framed supply chain integrity as a packaging problem Put a unique identifier on every pack seal it with an antitampering device check it at the point of dispensing and the falsified medicine threat would be contained Since February that model has been law across the European Union and it has worked better than many sceptics predicte...

B2B Lead Generation Pharma: High-ROI Tactics for European Markets

The European pharmaceutical industry can be called one of the most complicated and highly regulated markets in the world In the global market where a centralized approval system under the oversight of the European Medicines Agency EMA is required to the reimbursement systems specific to each country in Germany France Italy Spain and the Nordics market entry and market growth needs the accuracy of...

COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?

It was not uncommon to name the year as annus horribilis as the SARSCoV quickly spread all over the globe causing the first pandemic in years leading to devastating consequences on health economy and the society in general Neither drugs nor vaccines were available for more or less the whole first year of the pandemic causing devastation helplessness and uncertainty Since the beginning of the COV...

Key Stages in Pharmaceutical Formulation Development: A Complete Guide

One of the most significant operations in the field of drug study is pharmaceutical formulation development to ensure that the medications are distributed to the patients without harm and in the most appropriate manner This is a science that involves the transformation of an active pharmaceutical ingredient API into a solid efficient and convenient dosage form To researchers manufacturers and regu...

AI-Native Pharma: Redefining Enterprise Strategy Beyond Drug Discovery

For the better part of a decade artificial intelligence in pharma has been discussed almost entirely as a discovery story Boards have approved generative chemistry platforms protein structure prediction has moved from novelty to routine and the industry has grown comfortable describing AI as a way to find better molecules faster That framing is not wrong It is simply far too small

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys